Former Cipla CEO Umang Vohra Appointed As Executive Chairman & Group CEO Of Cohance Lifesciences

Cohance Lifesciences has appointed Umang Vohra as Executive Chairman, effective May 1, 2026, and Group Chief Executive Officer (CEO), effective May 20, 2026. He succeeds Vivek Sharma, who will step down for personal reasons and continue as an Advisor for nine months.

Vohra joins after serving as CEO and Managing Director (MD) of Cipla, where he led operations over the past decade. Earlier, he served as Chief Financial Officer & Executive Vice President (CFO & EVP) at Dr. Reddy’s Laboratories. He also held the position of Manager (Finance) at PepsiCo India and Eicher Ltd. He is a pharmaceutical industry executive with over three decades of experience in managing global healthcare businesses. Vohra holds a bachelor’s degree in engineering and a master’s degree in business administration (MBA) in management.

a

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: